Heng-Lan Kuo

A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models

Shu-Wha Lin, S. Kuo, Hui-Chin Peng, 2016, Thrombosis and Haemostasis.

NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities

S. Kuo, C. Chung, Chien-Hsin Chang, 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

NP‐313, 2‐acetylamino‐3‐chloro‐1,4‐naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A2 synthesis and calcium entry

S. Kuo, C. Chung, Chien-Hsin Chang, 2011, British journal of pharmacology.

The highly specific platelet glycoprotein (GP) VI agonist trowaglerix impaired collagen‐induced platelet aggregation ex vivo through matrix metalloproteinase‐dependent GPVI shedding

C. Chung, C.-C. Hsu, T. Huang, 2008, Journal of thrombosis and haemostasis : JTH.

Antithrombotic Effect of a Protein-Type I Class Snake Venom Metalloproteinase, Kistomin, Is Mediated by Affecting Glycoprotein Ib-von Willebrand Factor Interaction

Wen-Bin Wu, Chun-Chieh Hsu, Ya-hui Chang, 2007, Molecular Pharmacology.